Lv51
958 积分 2022-08-12 加入
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients with Advanced Lung Squamous Cell Carcinoma (SQUIN)
5小时前
已完结
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
5小时前
已完结
Progress in Detection of Insomnia Sleep Disorder: A Comprehensive Review
17天前
已完结
The Effects of Insomnia and Sleep Loss on Cardiovascular Disease
17天前
已完结
HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer
20天前
已完结
Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor–Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002)
2个月前
已完结
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial
2个月前
已完结
Therapeutic prospects of nectin-4 in cancer: applications and value
2个月前
已完结
Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial
4个月前
已完结
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
